(HealthDay)—A safety statement was issued yesterday by the U.S. Food and Drug Administration regarding risks found to be associated with the investigational use of Venclexta (venetoclax) for treatment of patients with multiple ...
Mar 25, 2019
0
5
A new treatment for people with multiple myeloma will now be available on the NHS in England.
Mar 12, 2019
0
2
Hope has emerged for patients with a serious type of bone marrow cancer as new research into a therapeutic drug has revealed improved outcomes and survival rates.
Dec 15, 2018
0
58
Cancer arises when cells lose control. Deciphering the "blueprint" of cancer cells—outlining how cancer cells hijack specific pathways for uncontrolled proliferation—will lead to more efficient ways to fight it. Joint ...
Dec 6, 2018
0
67
(HealthDay)—For patients with multiple myeloma in whom treatment with lenalidomide and a proteasome inhibitor has failed, progression-free survival (PFS) is longer in those receiving the immunostimulatory monoclonal antibody ...
Nov 8, 2018
0
0
Multiple myeloma (MM) is the second most common type of blood cancer where cancer cells accumulate in the bone marrow, crowding out healthy blood cells. Studies on MM development have traditionally focused mostly on DNA abnormalities, ...
Nov 1, 2018
0
0
Researchers at Mayo Clinic have identified three specific gene types that account for a known two-to-three-fold increase in myeloma diagnoses among African-Americans. Researchers also demonstrated the ability to study race ...
Oct 10, 2018
0
19
A small clinical trial has shown that a new drug has promise for targeting tumours in patients with an aggressive type of blood cancer.
Oct 8, 2018
0
26
A pioneering study into myeloma, a rare cancer, could lead to GPs using simple blood tests to improve early diagnosis.
Aug 14, 2018
0
78
A multidisciplinary team of researchers from the National University of Singapore (NUS) has developed an artificial intelligence (AI) technology platform that could potentially change the way drug combinations are being designed, ...
Aug 13, 2018
0
2
